ABSTRACT
INTRODUÇÃO: A fraqueza muscular adquirida em internações prolongadas é comum em cerca de 50 -80% dos pacientes onde apresentam evidências eletrofisiológicas de disfunção neuromuscular. A mobilização e a reabilitação precoce têm demonstrado melhorar os resultados funcionais e a qualidade de vida e neste contexto, a estimulação elétrica neuromuscular (NMS) tem positivas evidências auxiliando na preservação da síntese proteica e na prevenção de atrofia muscular durante o período de imobilização. OBJETIVO: Analisar os benefícios proporcionados pela eletroestimulação em pacientes internados na unidade de terapia intensiva. METODOLOGIA: Para realizar esta revisão, foi realizada uma busca nas seguintes bases de dados: SciELO, Medline, Lilacs, PEDro, PubMed e Cochrane, no período de junho a dezembro de 2018. Foram encontrados 106 artigos e 99 excluídos por não estarem de acordo com nossos descritores. No final, 7 artigos se enquadram nos critérios para a análise final. Os estudos foram selecionados primeiro pelo título, resumos e metodologias. Os critérios de inclusão dos estudos foram: comparador (es): parâmetros da EENM utilizados, força muscular e tempo de terapia por sessão, indivíduos maiores de 18 anos, homens e mulheres, necessitando de ventilação mecânica invasiva por mais de 24 horas. Estudos: Ensaios clínicos, coorte transversal, coorte longitudinal com esse tema. Não foram selecionados estudos de caso, artigos de revisão sistemática, resumos de congressos sobre o assunto, estudos fora do intervalo de tempo escolhido e outras técnicas de mobilização precoce. RESULTADOS: O número total de participantes incluídos nos estudos foi de 594 adultos, 323 em grupos experimentais e 271 em grupos controle, e todos os estudos investigaram os efeitos da NMS em pacientes críticos. Os estudos foram em adultos com diversos diagnósticos, houve grande variabilidade entre os protocolos NMS, número e tempo de sessão realizada. CONCLUSÃO: O NMS tem resultados significativos no aumento da força muscular, melhora a independência funcional, encurta o tempo de internação hospitalar, o tempo do uso de ventilação mecânica invasiva e níveis mais baixos de sedação. No entanto, ainda há necessidade de mais estudos com uma metodologia mais bem descrita para realmente investigar com mais precisão sobre o efeito isolado de NMS em pacientes críticos.
INTRODUCTION: Acquired muscle weakness in prolonged hospitalizations is common in approximately 50 -80% of hospitalized patients where all present electrophysiological evidence of neuromuscular dysfunction. Mobilization and early rehabilitation have been shown to improve functional results and quality of life and in this context, neuromuscular electrical stimulation (NMS) has positive evidences aiding in the preservation of protein synthesis and in the prevention of muscle atrophy during the immobilization period. OBJECTIVE: To analyze the benefits of electrostimulation in patients in the intensive care unit. METHODOLOGY: To carry out this review a search was performed in the following databases: SciELO, Medline, Lilacs, PEDro, PubMed and Cochrane, in the period from June to December 2018. 106 articles were found and 99 were excluded because they were not in accordance with our descriptors. In the end, 7 articles fit the criteria for the final analysis. The studies were selected first by the title, abstracts and methodologies. The criteria for inclusion of the studies were: comparator (es): NMS parameters used, muscle strength and therapy time per session, individuals over 18 years old, male and female, requiring invasive mechanical ventilation for more than 24 hours. Studies: Clinical trials, cross-sectional cohort, longitudinal cohort with this theme. No case studies, Systematic review articles, congress summaries on the subject, studies outside the chosen time interval, and other early mobilization techniques were selected. RESULTS: The total number of participants included in the studies was 594 adults, 323 in experimental groups and 271 in control groups, and all studies investigated the effects of NMS in critical patients. The studies were in adults with diverse diagnoses, there was great variability between the NMS protocols, number and time of session performed. CONCLUSION: The NMS has significant results in the increase of muscle strength, Improves functional independence, shortens hospital admission time, shortens time for invasive mechanical ventilation and lower levels of sedation. However, there is still a need for further studies with a better described methodology to actually investigate more accurately about the isolated effect of NMS in critical patients.
Subject(s)
Transcutaneous Electric Nerve Stimulation , Critical Care , Early AmbulationABSTRACT
Parkinson é uma doença de sintomas motores e não motores, podendo incluir neste último, a bexiga neurogênica, que se caracteriza por sintomas de urgência, com ou sem urge-incontinência, normalmente acompanhada de polaciúria e noctúria. Objetivo: Analisar a eletroestimulação transcutânea e a percutânea do nervo tibial para tratamento da bexiga hiperativa em Parkinsonianos. Metodologia: Foram incluídos todos os artigos que mencionaram o tratamento da bexiga hiperativa, com eletroestimulação transcutânea e percutânea do tibial posterior, em pacientes com Parkinson. Realizou-se a busca de março a novembro de 2017, nas bases de dados US National Library of Medicine (MEDLINE), Scientific Eletronic Library Online (SciELO), Physiotherapy Evidence Database (PEDro), Biblioteca Virtual em Saúde (BVS) e Google acadêmico, sem limites de data. Foram utilizados como descritores contidos nos Descritores em Ciências da Saúde (DeCS) as palavras-título: bexiga hiperativa, Parkinson e eletroestimulação transcutânea e percutânea do tibial posterior. Foram utilizados como descritores contidos no Medical Subject Headings (MeSH) as palavras-título: overactivity bladder, Parkinson"™s disease, electrical stimulation transcutaneous, percutaneous electrical stimulation. Resultados: Dos 8 artigos recuperados, 1 estava duplicado e 2 foram excluídos por não estarem disponíveis, restando cinco artigos: 2 ECRs, 2 experimentais e 1 estudo piloto. Conclusão: a terapia de eletroestimulação tibial, tanto transcutânea, quanto percutânea, se mostra benéfica para tratamento da bexiga hiperativa, em pacientes com Parkinson, porém, se faz necessário a realização de novos estudos, principalmente os de intervenção, para padronização do método. (AU)
Parkinson's disease is a disease of motor and non-motor symptoms, and may include neurogenic bladder, which is characterized by urgency symptoms, with or without urge incontinence. Objective: To analyze the transcutaneous and percutaneous electrostimulation of the tibial nerve for treatment of overactive bladder in Parkinsonians. Methodology: All articles mentioning the treatment of overactive bladder, with transcutaneous and percutaneous electrostimulation of the posterior tibial, were included in patients with Parkinson's disease. The search was carried out from March to November 2017, in the databases National Library of Medicine (Medline), Scientific Electronic Library Online (SciELO), Physiotherapy Evidence Database (PEDro), Virtual Health Library (VHL) and Google academic, without date limits. The descriptors included were: hyperactive bladder, Parkinson's and transcutaneous and percutaneous electrostimulation of the posterior tibial. The descriptors included in the Medical Subject Headings (MeSH) were: overactivity bladder, Parkinson's disease, electrical stimulation transcutaneous, percutaneous electrical stimulation. Results: Of the 8 articles retrieved, 1 was duplicated and 2 were excluded because they were not available, leaving five articles: 2 RCTs, 2 experimental and 1 pilot study. Conclusion: Transcutaneous and percutaneous tibial electrostimulation therapy is beneficial for the treatment of overactive bladder in patients with Parkinson disease. However, it is necessary to carry out new studies, especially interventional ones, to standardize the method. (AU)
Subject(s)
Humans , Tibial Nerve , Transcutaneous Electric Nerve Stimulation , Electric Stimulation , Urinary Bladder, Overactive , Parkinson Disease , Urinary Bladder, NeurogenicABSTRACT
OBJECTIVE@#To compare the differences in the clinical therapeutic effects on perimenopausal syndrome (PMS) between the combined treatment with the transcutaneous electrostimulation at Shuitu (ST 10) and the seed-pressure therapy at the auricular points and the hormone replacement therapy.@*METHODS@#A total of 64 PMS patients were divided into an observation group (30 cases) and a control group (34 cases) according to patient's willingness. In the observation group, the transcutaneous electrostimulation at Shuitu (ST 10) was combined with the seed-pressure therapy at the auricular points. The stimulation intensity at Shuitu (ST 10) was ranged from 15 to 20 mA, for 20 min in each treatment, twice a week. The 8 treatments made one course and 3 courses were required. Additionally, the seed-pressure therapy was used at neifenmi (CO), Shenmen (TF), luanchao, zigong, gan (CO), shen (CO), once a week, retained for 5 days. The 4-week treatment was as one course and a total of 3 courses were required. In the control group, the hormone replacement therapy was applied. On Day 5 of menstruation, progynova was prescribed for oral administration, 1 mg, once a day, continuously for 21 days. On Day 12 in the oral administration of progynova, dydrogesterone was used, 20 mg, once every day, continuously for 10 days. Totally, 3 courses were required. Separately, before treatment and in 1 and 3 months after treatment, Kuppermann score, the sexual hormone levels [follicle-stimulating hormone (FSH), luteinizing hormone (LH) and estradiol (E)] and the adverse reactions were observed in the patients of the two groups.@*RESULTS@#In 1 and 3 months after treatment, Kuppermann scores were reduced significantly as compared with those before treatment in the two groups (all 0.05). In the control group, the incidences of the adverse reactions such as vaginal bleeding, bread distending pain and endometrial thickening were higher than those in the observation group [17.6% (6/34) vs 0% (0/30), 20.6% (7/34) vs 3.3% (1/30), 8.8% (3/34) vs 0% (0/30), all <0.05].@*CONCLUSION@#The combined treatment with the transcutaneous electrostimulation at Shuitu (ST 10) and the seed-pressure therapy at the auricular points achieves the similar therapeutic effects on PMS as compared with the hormone replacement therapy. This combined therapy effectively relieves the clinical symptoms and improves the sexual hormone levels. The adverse reactions and the complications are less obviously as compared with the hormone replacement therapy.